SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-17-001541
Filing Date
2017-02-23
Accepted
2017-02-23 07:10:29
Documents
4
Period of Report
2017-02-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1700557_8k.htm 8-K 17679
2 EXHIBIT 99.1 t1700557_ex99-1.htm EX-99.1 23869
3 GRAPHIC t1700557_ex99-1p1.jpg GRAPHIC 10144
4 GRAPHIC t1700557_ex99-1p2.jpg GRAPHIC 3414
  Complete submission text file 0001571049-17-001541.txt   61726
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 17630718
SIC: 2834 Pharmaceutical Preparations